Mammary-like adenocarcinoma of the vulva associated to Paget's disease is exceedingly rare. So, it is very important to perform all the pathological and immunohistochemical investigations to achieve differential diagnosis from both a metastatic lesion from an orthotopic breast cancer and a vulvar adnexal tumor. This report describes a case of vulvar Paget's disease associated with underlying mammary-like adenocarcinoma diagnosed in the Department of Obstetrics and Gynecology of Farhat Hached university hospital of Sousse in Tunisia. We also review previously reported cases of primary breast-like carcinoma of the vulva with or without Paget's disease.
Introduction
Primary adenocarcinomas of the vulva are rare. However, a rare form of adenocarcinoma can arise from mammary-like vulvar glands displaying features of both eccrine and mammary glands. We report a case of vulvar Paget's disease associated with underlying mammary-like adenocarcinoma. To explore the possibility that this was a case of primary breast carcinoma of the vulva, we investigated the immunohistochemical characteristics of the tumor cells. We also review previously reported cases of primary breastlike carcinoma of the vulva with or without Paget's disease.
Patient and observation
A 41-year-old woman, gravida 4 para 4, presented with a left vulvar labia mass. There was no previous history of malignancy or breast disease. Her family history was not remarkable for carcinomas. 
Discussion
Vulva accounts for the majority of extra-mammary Paget's disease location (76%) [1] . The specific occurrence of primary breast-like carcinoma of the vulva is exceedingly rare with approximately 17 cases, including the present case, being reported in the literature between 1872 and 2013 [2] . n approximately 10-20% of cases, vulvar Paget's disease is known to be associated with invasive adenocarcinoma [3] . Involvement of the overlying epidermis with Paget's disease was observed in seven cases, including the present case.
A review of the literature found that the mean age of the patients was 60 year old. The most common symptoms are pruritus, burning pain, lump and occasionally painful erosion [3] . A visible lesion, typically an erythematous plaque is present in almost all patients.
The average dimension of the lesion is of about 2.5cm and the lesion is in the most of cases unilateral (bilateral in one case). Major labia are the most often involved site (15cases), followed by minor labia (5 cases) and clitoris (2 cases) [2] . Initially, these tumors were between these 3 types is essential to avoid potential confusion and unnecessary surgery [5] . Besides, the Yale experience reveals an association between outcome of extra-mammary Paget's disease and Her-2/neu over expression. It was found in this work that Her-2/neu over expression rate was higher in patients with invasive disease (71% versus 54%) [5] . This finding supports the possible therapeutic use of anti-Her-2/neu antibodies (Trastuzumab).
Besides, the Ki-67 and Cyclin D1 expression are found to be expressed at higher levels in invasive lesions than in situ lesions [6] .
The majority of case reports in the literature detail the surgical management of this tumor involving a wide local excision or radical vulvectomy with node dissection followed by adjuvant chemotherapy, hormonotherapy or radiation, similar to the management of an isolated malignant breast mass. In 10-20% of cases, vulvar Paget's disease is associated to other malignancies at other sites, as the breast, the rectum, the genitourinary tract and the cervix [7] . A Spanish study reports that vulvar extramammary Paget's disease was associated with adnexal adenocarcinoma in 4% of cases and with a distant malignancy in 20% of cases [7] . Due to the high incidence of coexisting malignancies at other sites, diagnosis of vulvar Paget's disease should lead to further investigations such as mammography, colonoscopy, colposcopy and cervical cytology [8] . We also suggest that patients with ectopic breast cancer should be followed-up as though they had à breast cancer, with à chest X-ray, liver ultrasound examination and total body bone scintigraphy to assess the most probable metastatic sites of the lesion. The evaluation of serum level of CA15.3 also appears to main to be a reliable biological marker to evaluate relapses and responses to chemotherapy in these patients [8] .
Abbott and Ahmed [9] concluded that aggressive surgical therapeutic regimens, particularly in the case of tumors localized to the skin, should be reassessed, given the morbidity faced by such therapy. They rather suggest that Mohs micrographic surgery can be adopted for tumors localized to the skin, especially in elderly patients or those with severe comorbid conditions. Given the high frequency of nodal disease at presentation with adenocarcinoma of mammary-like glands, the role of sentinel lymphadenectomy must be explored, especially when no evidence of such disease is apparent either clinically or radiographically [10] .
Conclusion

When
Paget's disease with underlying mammary-like adenocarcinoma of the vulva is established, it is very important to perform all the pathological and immunohistochemical investigations to achieve differential diagnosis from both a metastatic lesion from an orthotopic breast cancer and a vulvar adnexal tumor. Treatment and follow-up should be the same as if it was an orthotopic breast neoplasm. 
